These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10507290)

  • 1. Early suppression of lymphoproliferative response in dogs with natural infection by Leishmania infantum.
    De Luna R; Vuotto ML; Ielpo MT; Ambrosio R; Piantedosi D; Moscatiello V; Ciaramella P; Scalone A; Gradoni L; Mancino D
    Vet Immunol Immunopathol; 1999 Sep; 70(1-2):95-103. PubMed ID: 10507290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals.
    Gradoni L; Foglia Manzillo V; Pagano A; Piantedosi D; De Luna R; Gramiccia M; Scalone A; Di Muccio T; Oliva G
    Vaccine; 2005 Nov; 23(45):5245-51. PubMed ID: 16054272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis.
    Martínez-Moreno A; Moreno T; Martínez-Moreno FJ; Acosta I; Hernández S
    Vet Immunol Immunopathol; 1995 Oct; 48(3-4):209-20. PubMed ID: 8578681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis.
    Nieto CG; García-Alonso M; Requena JM; Mirón C; Soto M; Alonso C; Navarrete I
    Vet Immunol Immunopathol; 1999 Feb; 67(2):117-30. PubMed ID: 10077418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progress on the diagnosis technology of canine visceral leishmaniasis].
    Ding D; Wang JY
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Oct; 30(5):406-10. PubMed ID: 23484286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
    Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G
    Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An experimental protocol for the establishment of dogs with long-term cellular immune reactions to Leishmania antigens.
    Teixeira MC; Oliveira GG; Santos PO; Bahiense TC; da Silva VM; Rodrigues MS; Larangeira DF; Dos-Santos WL; Pontes-de-Carvalho LC
    Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):182-9. PubMed ID: 21537678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine visceral leishmaniasis: a comparative study of real-time PCR, conventional PCR, and direct agglutination on sera for the detection of Leishmania infantum infection.
    Mohammadiha A; Haghighi A; Mohebali M; Mahdian R; Abadi AR; Zarei Z; Yeganeh F; Kazemi B; Taghipour N; Akhoundi B; Barati M; Mahmoudi MR
    Vet Parasitol; 2013 Feb; 192(1-3):83-90. PubMed ID: 23153824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine Leishmania vaccines: still a long way to go.
    Gradoni L
    Vet Parasitol; 2015 Feb; 208(1-2):94-100. PubMed ID: 25620293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Leishmania (Leishmania) infantum excreted-secreted antigens for detection of canine leishmaniasis.
    Pinedo-Cancino V; Laurenti MD; Kesper N; Umezawa ES
    Acta Trop; 2016 Sep; 161():41-3. PubMed ID: 27212707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response against Leishmania antigens in dogs naturally and experimentally infected with Leishmania infantum.
    Rhalem A; Sahibi H; Guessous-Idrissi N; Lasri S; Natami A; Riyad M; Berrag B
    Vet Parasitol; 1999 Mar; 81(3):173-84. PubMed ID: 10190861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inflammatory cytokine effect of Pam3CSK4 TLR2 agonist alone or in combination with Leishmania infantum antigen on ex-vivo whole blood from sick and resistant dogs.
    Martínez-Orellana P; Quirola-Amores P; Montserrat-Sangrà S; Ordeix L; Llull J; Álvarez-Fernández A; Solano-Gallego L
    Parasit Vectors; 2017 Mar; 10(1):123. PubMed ID: 28288677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis.
    Leandro C; Santos-Gomes GM; Campino L; Romão P; Cortes S; Rolão N; Gomes-Pereira S; Riça Capela MJ; Abranches P
    Vet Immunol Immunopathol; 2001 May; 79(3-4):273-84. PubMed ID: 11389961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.
    Strauss-Ayali D; Baneth G; Shor S; Okano F; Jaffe CL
    Int J Parasitol; 2005 Jan; 35(1):63-73. PubMed ID: 15619517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of immune responses in dogs with canine visceral leishmaniasis before, and after, drug treatment.
    Rhalem A; Sahibi H; Lasri S; Jaffe CL
    Vet Immunol Immunopathol; 1999 Oct; 71(1):69-76. PubMed ID: 10522787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry.
    Silvestre R; Santarém N; Cunha J; Cardoso L; Nieto J; Carrillo E; Moreno J; Cordeiro-da-Silva A
    Vet Parasitol; 2008 Nov; 158(1-2):23-30. PubMed ID: 18848397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.
    Petitdidier E; Pagniez J; Papierok G; Vincendeau P; Lemesre JL; Bras-Gonçalves R
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004614. PubMed ID: 27223609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of the Leishmania infantum-specific antibody repertoires and the autoantibody repertoires between asymptomatic and symptomatic dogs.
    Chaabouni A; Boubaker Elandoulsi R; Mhadhbi M; Gharbi M; Sassi A
    Vet Parasitol; 2018 Sep; 261():9-17. PubMed ID: 30253856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.